Lv65
1710 积分 2022-02-16 加入
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
3天前
已完结
The evolution of the obesity drug market
26天前
已完结
Breakthrough therapy designations in China and the United States
1个月前
已完结
Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion
2个月前
已完结
Can amylin-based drugs upstage GLP-1 agonists?
2个月前
已完结
The EGFRvIII variant in glioblastoma multiforme
2个月前
已完结
A phase 1 study of ABT-806 in subjects with advanced solid tumors
2个月前
已完结
Inhibition of pyruvate dehydrogenase kinase 4 ameliorates kidney ischemia-reperfusion injury by reducing succinate accumulation during ischemia and preserving mitochondrial function during reperfusion
2个月前
已完结
Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations
2个月前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors
2个月前
已完结
皖公网安备34019202002308
